-transparent.png){kind=logo}
After a 500-mg dose of cefaclor, the mean peak plasma level was 12.4 mug/ml and after a 250-mg dose it was 5 mug/ml in normal volunteers. Food intake significantly reduced absorption. Probenecid prolonged plasma levels. Mean plasma half-life in normal volunteers was 0.8 h. Only about 50% of the dose was excreted in the urine within 4 h in normal volunteers. Plasma half-life in patients with renal insufficiency was only about 3 h, which suggests that cefaclor may be eliminated by nonrenal mechanisms in humans. Urinary levels of cefaclor were adequate to inhibit susceptible pathogens even in patients with moderately severe renal failure. Plasma half-life during hemodialysis was 2.1 h and rose to 2.8 h after dialysis.
J Santoro, and
B N Agarwal, and
R Martinelli, and
N Wenger, and
M E Levison
December 1977,
Antimicrobial agents and chemotherapy,
J Santoro, and
B N Agarwal, and
R Martinelli, and
N Wenger, and
M E Levison
May 1988,
Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
J Santoro, and
B N Agarwal, and
R Martinelli, and
N Wenger, and
M E Levison
August 1984,
British journal of anaesthesia,
J Santoro, and
B N Agarwal, and
R Martinelli, and
N Wenger, and
M E Levison
January 1981,
Therapie,
J Santoro, and
B N Agarwal, and
R Martinelli, and
N Wenger, and
M E Levison
January 1972,
The Journal of clinical pharmacology and new drugs,
J Santoro, and
B N Agarwal, and
R Martinelli, and
N Wenger, and
M E Levison
January 1995,
Acta radiologica. Supplementum,
J Santoro, and
B N Agarwal, and
R Martinelli, and
N Wenger, and
M E Levison
January 1987,
Clinical pharmacology and therapeutics,
J Santoro, and
B N Agarwal, and
R Martinelli, and
N Wenger, and
M E Levison
October 1973,
The Journal of infectious diseases,
J Santoro, and
B N Agarwal, and
R Martinelli, and
N Wenger, and
M E Levison
July 1983,
Journal of clinical pharmacology,
J Santoro, and
B N Agarwal, and
R Martinelli, and
N Wenger, and
M E Levison
March 1986,
European journal of anaesthesiology,
